A multisite randomized controlled trial of Seeking Safety vs. Relapse Prevention Training for women with co-occurring posttraumatic stress disorder and substance use disorders.

Ingo Schäfer, Annett Lotzin, Philipp Hiller, Susanne Sehner, Martin Driessen, Thomas Hillemacher, Martin Schäfer, Norbert Scherbaum, Barbara Schneider, Johanna Grundmann
Author Information
  1. Ingo Schäfer: Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  2. Annett Lotzin: Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  3. Philipp Hiller: Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  4. Susanne Sehner: Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  5. Martin Driessen: Department of Psychiatry and Psychotherapy Bethel, Ev. Klinikum Bielefeld, Bielefeld, Germany.
  6. Thomas Hillemacher: Department of Psychiatry and Psychotherapy, Paracelsus University Nuremberg, Nürnberg, Germany.
  7. Martin Schäfer: Department of Psychiatry, Psychotherapy and Addiction Medicine, Lehrkrankenhaus der Universität Duisburg-Essen, Essen, Germany.
  8. Norbert Scherbaum: Department of Psychiatry and Psychotherapy, LVR-Klinik Essen, University Duisburg-Essen, Essen, Germany.
  9. Barbara Schneider: Department of Addictive Disorders and Psychiatry, LVR-Klinik Cologne, Cologne, Germany.
  10. Johanna Grundmann: Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Abstract

: Co-occurring posttraumatic stress disorder (PTSD) and substance use disorders (SUD) are associated with a more severe course and worse outcome than either disorder alone. In Europe, few treatments have been evaluated for PTSD and SUD. Seeking Safety, a manualized, integrated, cognitive-behavioural treatment, has been shown to be effective in studies in the USA. : To test the efficacy of Seeking Safety plus treatment as usual (TAU) in female outpatients with PTSD and SUD compared to Relapse Prevention Training (RPT) plus TAU and TAU alone. : In five German study centres a total of  343 women were randomized into one of the three study conditions. PTSD severity (primary outcome), substance use, depression and emotion dysregulation (secondary outcomes) were assessed at baseline, post-treatment, as well as at three months and six months post-treatment. : Treatment participants attended  6.6 sessions (Seeking Safety) and  6.1 sessions (RPT). In an intent-to-treat analysis, Seeking Safety plus TAU, RPT plus TAU and TAU alone showed comparable decreases in PTSD severity over the course of the study. Seeking Safety plus TAU showed superior efficacy to TAU alone on depression and emotion regulation and RPT plus TAU was more effective than TAU alone on number of substance-free days and alcohol severity. Minimum-dose analyses suggest additional effects of both programmes among participants who attended at least eight group sessions. : With respect to PTSD symptoms, a brief dose of Seeking Safety and RPT in addition to TAU was not superior to TAU alone in women with PTSD and SUD. However, Seeking Safety and RPT showed greater reductions than TAU alone in other domains of psychopathology and substance use outcomes respectively. Future studies should investigate further variables, such as what aspects of each treatment appeal to particular patients and how best to disseminate them.

Keywords

References

  1. J Subst Abuse Treat. 2001 Mar;20(2):121-7 [PMID: 11306214]
  2. Am J Psychiatry. 2001 Aug;158(8):1184-90 [PMID: 11481147]
  3. Compr Psychiatry. 2002 Nov-Dec;43(6):413-9 [PMID: 12439826]
  4. J Subst Abuse Treat. 1992;9(3):199-213 [PMID: 1334156]
  5. Alcohol Clin Exp Res. 2004 Mar;28(3):441-7 [PMID: 15084902]
  6. Am J Psychiatry. 2004 Aug;161(8):1426-32 [PMID: 15285969]
  7. Drug Alcohol Depend. 2005 Mar 7;77(3):243-9 [PMID: 15734224]
  8. Clin Psychol Rev. 2005 Sep;25(6):813-23 [PMID: 15967556]
  9. Psychiatr Serv. 2005 Oct;56(10):1213-22 [PMID: 16215186]
  10. J Psychoactive Drugs. 2005 Dec;37(4):425-35 [PMID: 16480170]
  11. Addict Behav. 2006 Nov;31(11):2063-73 [PMID: 16580784]
  12. Drug Alcohol Depend. 2007 Jan 5;86(1):1-21 [PMID: 16759822]
  13. Addict Behav. 2007 May;32(5):902-11 [PMID: 16857322]
  14. J Behav Health Serv Res. 2006 Oct;33(4):453-63 [PMID: 16858633]
  15. J Stud Alcohol Drugs. 2007 May;68(3):353-61 [PMID: 17446974]
  16. Am J Psychiatry. 2007 Apr;164(4 Suppl):5-123 [PMID: 17569411]
  17. Curr Opin Psychiatry. 2007 Nov;20(6):614-8 [PMID: 17921765]
  18. Alcohol Clin Exp Res. 2008 Mar;32(3):481-8 [PMID: 18215214]
  19. J Subst Abuse Treat. 2008 Oct;35(3):304-11 [PMID: 18294804]
  20. Psychiatr Serv. 2008 Sep;59(9):996-1003 [PMID: 18757592]
  21. Psychol Addict Behav. 2008 Dec;22(4):533-43 [PMID: 19071978]
  22. J Consult Clin Psychol. 2009 Aug;77(4):607-19 [PMID: 19634955]
  23. Drug Alcohol Depend. 2010 Sep 1;111(1-2):114-9 [PMID: 20537811]
  24. Psychiatry Res. 2011 Mar 30;186(1):85-90 [PMID: 20667600]
  25. J Anxiety Disord. 2011 Apr;25(3):456-65 [PMID: 21168991]
  26. Addiction. 2012 Mar;107(3):578-86 [PMID: 21923756]
  27. J Trauma Dissociation. 2012;13(1):88-101 [PMID: 22211443]
  28. Alcohol Clin Exp Res. 2012 Jun;36(6):1099-107 [PMID: 22420670]
  29. J Anxiety Disord. 2012 Jun;26(5):617-23 [PMID: 22480715]
  30. Eur J Psychotraumatol. 2012;3:null [PMID: 22893849]
  31. Springerplus. 2013 May 14;2(1):222 [PMID: 23853744]
  32. JAMA. 2013 Aug 7;310(5):488-95 [PMID: 23925619]
  33. Psychother Res. 2015;25(5):565-82 [PMID: 24967646]
  34. J Psychoactive Drugs. 2014 Oct-Dec;46(4):295-302 [PMID: 25188699]
  35. Addiction. 2013 Aug;108(8):1397-1410 [PMID: 25328957]
  36. J Consult Clin Psychol. 2015 Apr;83(2):359-69 [PMID: 25622199]
  37. Clin Psychol Rev. 2015 Jun;38:25-38 [PMID: 25792193]
  38. J Psychoactive Drugs. 2015 Nov-Dec;47(5):401-8 [PMID: 26514284]
  39. Drug Alcohol Depend. 2016 Jun 1;163:242-6 [PMID: 27114205]
  40. JAMA Psychiatry. 2017 Jan 1;74(1):28-36 [PMID: 27893032]
  41. Alcohol Clin Exp Res. 2017 Apr;41(4):681-702 [PMID: 28055143]
  42. Eur J Psychotraumatol. 2017 Mar 31;8(1):1304114 [PMID: 28451071]
  43. Psychother Psychosom. 2017;86(3):150-161 [PMID: 28490022]
  44. JAMA. 2018 Jan 23;319(4):343-345 [PMID: 29362777]
  45. Eur J Psychotraumatol. 2018 Jan 15;8(sup7):1418103 [PMID: 29372010]
  46. Eur J Psychotraumatol. 2017 Oct 09;8(1):1375338 [PMID: 29435198]
  47. Subst Use Misuse. 2018 Sep 19;53(11):1788-1800 [PMID: 29461920]
  48. J Trauma Stress. 1998 Jul;11(3):437-56 [PMID: 9690186]

Word Cloud

Created with Highcharts 10.0.0TAUSeekingSafetyPTSDaloneusesubstancetreatmentplusRPT:disorderSUDRelapsePreventionseveritystressdisordersTrainingstudywomenrandomizeddepressionemotionsessionsshowedalcoholgroupposttraumaticcourseoutcomeeffectivestudiesefficacyusualcomparedthreeconditionsoutcomespost-treatmentparticipantsattended 6comparablesuperiorregulationcontrolledtrialco-occurringabusedrugimprovedCo-occurringassociatedsevereworseeitherEuropetreatmentsevaluatedmanualizedintegratedcognitive-behaviouralshownUSAtestfemaleoutpatientsfiveGermancentrestotal 343oneprimarydysregulationsecondaryassessedbaselinewellthree monthssix monthsTreatment61intent-to-treatanalysisdecreasesnumbersubstance-freedaysMinimum-doseanalysessuggestadditionaleffectsprogrammesamongleasteightrespectsymptomsbriefdoseadditionHowevergreaterreductionsdomainspsychopathologyrespectivelyFutureinvestigatevariablesaspectsappealparticularpatientsbestdisseminatethemmultisitevsPosttraumaticaddictiondualdiagnosisrelapsepreventiontraumaprogrammeanothercognitivebehavioural•Decreases

Similar Articles

Cited By